Nephrology and Renal Transplantation Department, Bicetre Hospital, Paris, France.
Transpl Int. 2011 Jun;24(6):582-7. doi: 10.1111/j.1432-2277.2011.01237.x. Epub 2011 Feb 26.
Renal transplantation in patients with autosomal dominant polycystic kidney disease (ADPKD) is a medical and surgical challenge. Detailed longitudinal epidemiological studies on large populations are lacking and it is mandatory to care better for these patients. The success of such a project requires the development of a validated epidemiological database. Herein, we present the results of the largest longitudinal study to date on renal transplant in patients with ADPKD. The 15-year outcomes following renal transplantation of 534 ADPKD patients were compared with 4779 non-ADPKD patients. This comprehensive, longitudinal, multicenter French study was performed using the validated database, DIVAT (Données Informatisées et VAlidées en Transplantaion). We demonstrate that renal transplantation in ADPKD is associated with better graft survival, more thromboembolic complications, more metabolic complications, and increased incidence of hypertension, whereas the prevalence of infections is not increased. This study provides important new insights that could lead to a better care for renal transplant patients with ADPKD.
常染色体显性多囊肾病(ADPKD)患者的肾移植是一个医学和外科挑战。缺乏对大型人群进行详细的纵向流行病学研究,因此必须更好地照顾这些患者。此类项目的成功需要开发经过验证的流行病学数据库。在此,我们介绍了迄今为止最大的 ADPKD 患者肾移植的纵向研究结果。将 534 例 ADPKD 患者肾移植后的 15 年结果与 4779 例非 ADPKD 患者进行了比较。这项全面的、纵向的、多中心的法国研究使用了经过验证的数据库 DIVAT(Données Informatisées et VAlidées en Transplantaion)进行。我们证明,ADPKD 患者的肾移植与更好的移植物存活率、更多的血栓栓塞并发症、更多的代谢并发症以及高血压发生率增加有关,而感染的发生率并没有增加。这项研究提供了重要的新见解,可能会导致更好地照顾 ADPKD 肾移植患者。